lobbying_activities: 2181463

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2181463	05c4990a-118a-4aea-857b-525cf647aee2	Q3	RED+BLUE STRATEGIES	400693064	CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP)	2018	third_quarter	MMM	Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces. S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system. Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers. Issues related to making health care in the United States of America more transparent and consumer-focused.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2018-10-09T15:36:28.393000-04:00